Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Quinolines"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 7407
Tytuł:
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Autorzy:
Dorkenoo AM; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo. .
Warsame M; School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
Ataba E; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Hemou M; Service de Pédiatrie, Centre Hospitalier Universitaire Campus, Lomé, Togo.
Yakpa K; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Sossou E; Service des Laboratoires, Centre Hospitalier Universitaire Sylvanus Olympio Lomé, Lomé, Togo.
Mitigmsagou M; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Teou CD; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Caspar E; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.
Ma L; Biomics Platform, C2RT, Institut Pasteur, 75015, Paris, France.
Djadou KE; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Atcha-Oubou T; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Rasmussen C; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Menard D; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.; Malaria Genetics and Resistance Unit, Institut Pasteur, Université Paris Cité, INSERM U1201, 75015, Paris, France.; Malaria Parasite Biology and Vaccines, Institut Pasteur, Université Paris Cité, 75015, Paris, France.; Laboratory of Parasitology and Medical Mycology, CHU Strasbourg, 67000, Strasbourg, France.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2024 Apr 03; Vol. 23 (1), pp. 92. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Quinolines*/pharmacology
Quinolines*/therapeutic use
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/parasitology
Malaria*/drug therapy
Piperazines*
Artemisinins*
Child ; Adult ; Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether, Lumefantrine Drug Combination/pharmacology ; Prevalence ; Togo/epidemiology ; Prospective Studies ; Artemether/therapeutic use ; Drug Resistance ; Tetrahydrofolate Dehydrogenase/genetics ; Biomarkers ; Drug Combinations ; Plasmodium falciparum/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
New Library of Iodo-Quinoline Derivatives Obtained by an Alternative Synthetic Pathway and Their Antimicrobial Activity.
Autorzy:
Al-Matarneh CM; Center of Advanced Research in Bionanoconjugates and Biopolymers, 'Petru Poni' Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.; Research Institute of the University of Bucharest-ICUB, 91-95 Spl. Independentei, 050095 Bucharest, Romania.
Nicolescu A; NMR Laboratory 'Petru Poni' Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
Marinaş IC; Research Institute of the University of Bucharest-ICUB, 91-95 Spl. Independentei, 050095 Bucharest, Romania.
Găboreanu MD; Research Institute of the University of Bucharest-ICUB, 91-95 Spl. Independentei, 050095 Bucharest, Romania.
Shova S; Department of Inorganic Polymers 'Petru Poni' Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
Dascălu A; Center of Advanced Research in Bionanoconjugates and Biopolymers, 'Petru Poni' Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
Silion M; Physics of Polymers and Polymeric Materials Department, 'Petru Poni' Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
Pinteală M; Center of Advanced Research in Bionanoconjugates and Biopolymers, 'Petru Poni' Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Feb 07; Vol. 29 (4). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Infective Agents*/chemistry
Iodine*
Quinolines*/chemistry
Spectroscopy, Fourier Transform Infrared
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Autorzy:
Wegen S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany. .; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany. .
Claus K; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Linde P; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Rosenbrock J; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Trommer M; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.; Department of Radiation Oncology, Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Melbourne, Australia.
Zander T; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Tuchscherer A; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Bruns C; Department of General, Visceral, Cancer and Transplantation Surgery, Faculty of Medicine, with University Hospital Cologne, Cologne, Germany.
Schlößer HA; Department of General, Visceral, Cancer and Transplantation Surgery, Faculty of Medicine, with University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schröder W; Department of General, Visceral, Cancer and Transplantation Surgery, Faculty of Medicine, with University Hospital Cologne, Cologne, Germany.
Eich ML; Institute of Pathology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Fischer T; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schomäcker K; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Drzezga A; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine, Molecular Organization of the Brain, Forschungszentrum Jülich, INM-2, Cologne, Germany.
Kobe C; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Sabine Roth K; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Weindler JJ; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Apr 04; Vol. 19 (1), pp. 44. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Quinolines*
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/radiotherapy
Humans ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18 ; Positron-Emission Tomography ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A novel quinoline with airway relaxant effects and anti-inflammatory properties.
Autorzy:
Bergwik J; Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, & Palliative Medicine, Lund University and Skåne University Hospital, Lund, Sweden.
Liu J; Experimental Asthma and Allergy Research Unit, Institute of Environmental Medicine (IMM), Karolinska Institutet, Biomedicum, Solnavägen 9, 171 65, Stockholm, Sweden.
Padra M; Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, & Palliative Medicine, Lund University and Skåne University Hospital, Lund, Sweden.
Bhongir RKV; Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, & Palliative Medicine, Lund University and Skåne University Hospital, Lund, Sweden.
Tanner L; Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, & Palliative Medicine, Lund University and Skåne University Hospital, Lund, Sweden.
Xiang Y; Experimental Asthma and Allergy Research Unit, Institute of Environmental Medicine (IMM), Karolinska Institutet, Biomedicum, Solnavägen 9, 171 65, Stockholm, Sweden.
Lundblad M; Arcede Pharma AB, Medicon Village, Lund, Sweden.
Egesten A; Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, & Palliative Medicine, Lund University and Skåne University Hospital, Lund, Sweden.
Adner M; Experimental Asthma and Allergy Research Unit, Institute of Environmental Medicine (IMM), Karolinska Institutet, Biomedicum, Solnavägen 9, 171 65, Stockholm, Sweden. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Mar 30; Vol. 25 (1), pp. 146. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Bronchial Hyperreactivity*/chemically induced
Bronchial Hyperreactivity*/drug therapy
Asthma*/metabolism
Quinolines*/adverse effects
Rats ; Mice ; Humans ; Animals ; Dogs ; NF-kappa B/metabolism ; Lipopolysaccharides/pharmacology ; Bronchoalveolar Lavage Fluid ; Lung/metabolism ; Cytokines/metabolism ; Chemokines/metabolism ; Anti-Inflammatory Agents/adverse effects ; Inflammation/pathology ; Budesonide/pharmacology ; Ovalbumin/toxicity ; Mice, Inbred BALB C
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.
Autorzy:
Li H; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Feng H; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang T; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu J; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen X; Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu S; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu L; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang S; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Y; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jia W; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ji X; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Cheng X; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Zhao R; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 21; Vol. 23 (1), pp. 59. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/genetics
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Indoles*
Quinolines*
Humans ; Animals ; Mice ; RNA, Circular/genetics ; Tumor Suppressor Protein p53 ; Prospective Studies ; Cell Proliferation/genetics ; Biomarkers ; Ubiquitin Thiolesterase/metabolism ; Cyclins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long Non-Coding RNA-Cardiac-Inducing RNA 6 Mediates Repair of Infarcted Hearts by Inducing Mesenchymal Stem Cell Differentiation into Cardiogenic Cells through Cyclin-Dependent Kinase 1.
Autorzy:
Cui X; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Dong H; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Luo S; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Zhuang B; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Li Y; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Zhong C; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Ma Y; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Hong L; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji 133002, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 19; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*/metabolism
Myocardial Infarction*/genetics
Myocardial Infarction*/therapy
Myocardial Infarction*/metabolism
Quinolines*
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Thiazoles*
Animals ; Mice ; CDC2 Protein Kinase/genetics ; CDC2 Protein Kinase/metabolism ; Cell Differentiation/genetics ; Mice, Inbred C57BL ; Myocytes, Cardiac/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: A treatment with Chinese characteristics.
Autorzy:
Wu J; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Wu J; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Li S; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Luo M; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of General Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Zeng Z; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Li Y; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Fu Y; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Li H; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Liu D; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Ou X; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Lin Z; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of General Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Wei S; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of General Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Yan M; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Pokaż więcej
Źródło:
Bioscience trends [Biosci Trends] 2024 Mar 19; Vol. 18 (1), pp. 42-48. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/therapy
Chemoembolization, Therapeutic*
Phenylurea Compounds*
Quinolines*
Humans ; China
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan.
Autorzy:
Yamashita T; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.
Suzuki N; Eisai Co., Ltd., Tokyo, Japan.
Motoyoshi K; Eisai Co., Ltd., Tokyo, Japan.
Zhu W; Eisai Co., Ltd., Tokyo, Japan.
Furuse J; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 08; Vol. 19 (3), pp. e0298420. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Antineoplastic Agents*/adverse effects
Phenylurea Compounds*
Quinolines*
Humans ; Japan ; Prospective Studies ; Product Surveillance, Postmarketing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis.
Autorzy:
She X; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Yin D; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Guo Q; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Tang Y; Department of Pharmacy, School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Wang S; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. .
Wang X; Central Laboratory, Shanxi Hospital of Integrated Traditional Chinese and Western Medicine, Taiyuan, Shanxi, People's Republic of China. .; Key Laboratory of Research and Development of Traditional Chinese Medicine Preparations, Taiyuan, Shanxi, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5592. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Anilides*
Carcinoma, Renal Cell*/drug therapy
Indazoles*
Kidney Neoplasms*/pathology
Phenylurea Compounds*
Pyridines*
Pyrimidines*
Quinolines*
Sulfonamides*
Aged ; Humans ; Male ; Axitinib/therapeutic use ; Bayes Theorem ; Electrolytes ; Pharmacovigilance ; Retrospective Studies ; Sorafenib/adverse effects ; Sunitinib/adverse effects ; United States ; United States Food and Drug Administration ; Female ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
RAR Inhibitors Display Photo-Protective and Anti-Inflammatory Effects in A2E Stimulated RPE Cells In Vitro through Non-Specific Modulation of PPAR or RXR Transactivation.
Autorzy:
Fontaine V; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
Boumedine T; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
Monteiro E; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
Fournié M; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
Gersende G; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
Sahel JA; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.; Fondation Ophtalmologique Rothschild, 29 rue Manin, 75019 Paris, France.; Department of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Picaud S; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
Veillet S; Biophytis, Sorbonne Université, BC9, 4 place Jussieu, 75005 Paris, France.
Lafont R; Biophytis, Sorbonne Université, BC9, 4 place Jussieu, 75005 Paris, France.
Latil M; Biophytis, Sorbonne Université, BC9, 4 place Jussieu, 75005 Paris, France.
Dilda PJ; Biophytis, Sorbonne Université, BC9, 4 place Jussieu, 75005 Paris, France.
Camelo S; Biophytis, Sorbonne Université, BC9, 4 place Jussieu, 75005 Paris, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 06; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carotenoids*
Macular Degeneration*/metabolism
para-Aminobenzoates*
Peroxisome Proliferator-Activated Receptors*/metabolism
Quinolines*
Anti-Inflammatory Agents ; Drug Inverse Agonism ; Inflammation ; Retinoic Acid Receptor alpha/metabolism ; Retinoid X Receptors/metabolism ; Retinoids/metabolism ; Transcriptional Activation ; Vascular Endothelial Growth Factor A/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.
Autorzy:
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. .
Fujiwara K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Yunokawa M; Department of Gynecology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
Ushijima K; Department of Obstetrics and Gynecology, Kurume University Hospital, Fukuoka, Japan.
Suzuki S; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
Shikama A; Department of Obstetrics and Gynecology, University of Tsukuba Hospital, Ibaraki, Japan.
Minobe S; Division of Gynecologic Oncology, Hokkaido Cancer Center, Hokkaido, Japan.
Usami T; Department of Obstetrics and Gynecology, Ehime University Hospital, Ehime, Japan.
Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
Kim BG; Division of Gynecologic Cancer, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Wang PH; Institute of Clinical Medicine, National Yang Ming Chiao Tung University; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital; Female Cancer Foundation, Taipei, Taiwan; China Medical University Hospital, Taichung, Taiwan.
Chang TC; Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital and Chang Gung University Medical College, Kueishan, Taoyuan City, Taiwan.
Yamamoto K; Oncology Science Unit, MSD K.K., Tokyo, Japan.
Han S; Biostatistics & Research Decision Sciences, MSD K.K., Tokyo, Japan.
McKenzie J; Eisai Inc., Nutley, NJ, USA.
Orlowski RJ; Global Clinical Development, Merck & Co., Inc., Rahway, NJ, USA.
Miura T; Clinical Oncology, Eisai Co., Ltd., Tokyo, Japan.
Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Man Kim Y; Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan, Seoul, Korea.
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Mar; Vol. 35 (2), pp. e40. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/etiology
Physicians*
Phenylurea Compounds*
Quinolines*
Antibodies, Monoclonal, Humanized*
Humans ; Female ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/etiology ; Asia, Eastern/epidemiology ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Conjugates of Indolo[2,3- b ]quinoline as Anti-Pancreatic Cancer Agents: Design, Synthesis, Molecular Docking and Biological Evaluations.
Autorzy:
Cybulski M; Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute, 01-793 Warsaw, Poland.
Sidoryk K; Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute, 01-793 Warsaw, Poland.
Zaremba-Czogalla M; Department of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland.
Trzaskowski B; Chemical and Biological Systems Simulation Lab, Center of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.
Kubiszewski M; Pharmaceutical Analysis Laboratory, Łukasiewicz Research Network-Industrial Chemistry Institute, 01-793 Warsaw, Poland.
Tobiasz J; Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute, 01-793 Warsaw, Poland.
Jaromin A; Department of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland.
Michalak O; Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute, 01-793 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 22; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*
Quinolines*
Antineoplastic Agents*
Humans ; Molecular Docking Simulation ; Pancreatic Hormones ; Coumaric Acids ; Multienzyme Complexes ; DNA ; Structure-Activity Relationship ; Molecular Structure ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.
Autorzy:
Kositz C; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK. .
Vasileva H; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK.
Mohammed N; Disease Control and Elimination, Medical Research Council Unit Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM), Fajara, The Gambia.
Achan J; Disease Control and Elimination, Medical Research Council Unit Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM), Fajara, The Gambia.
Dabira ED; Disease Control and Elimination, Medical Research Council Unit Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM), Fajara, The Gambia.
D'Alessandro U; Disease Control and Elimination, Medical Research Council Unit Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM), Fajara, The Gambia.
Bradley J; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK.
Marks M; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK.; Hospital for Tropical Diseases, University College London Hospital, London, UK.; Division of Infection and Immunity, University College London, London, UK.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2024 Feb 22; Vol. 23 (1), pp. 54. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials*
Artemisinins*
Malaria*/prevention & control
Malaria*/drug therapy
Piperazines*
Quinolines*/therapeutic use
Adult ; Child ; Humans ; Ivermectin/therapeutic use ; Mass Drug Administration ; Risk Factors ; Child, Preschool ; Adolescent ; Middle Aged ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Autorzy:
Soll D; Department of Endocrinology and Metabolism, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Luisenstr. 13, 10117, Berlin, Germany. .
Bischoff P; Institute of Pathology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Frisch A; Department of Radiology (CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, 13353, Berlin, Germany.
Jensen M; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, 10117, Berlin, Germany.
Karadeniz Z; Institute of Pathology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
Mogl MT; Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
Horst D; Institute of Pathology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Penzkofer T; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Radiology (CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, 13353, Berlin, Germany.
Spranger J; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, 10117, Berlin, Germany.; Charité-Center for Cardiovascular Research (CCR), Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; German Center for Diabetes Research (DZD), 85784, Neuherberg, Germany.; NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam, 14558, Nuthetal, Germany.
Keilholz U; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Chariteplatz 1, 10117, Berlin, Germany.
Mai K; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, 10117, Berlin, Germany.; Charité-Center for Cardiovascular Research (CCR), Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; German Center for Diabetes Research (DZD), 85784, Neuherberg, Germany.; NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam, 14558, Nuthetal, Germany.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2024 Feb 22; Vol. 24 (1), pp. 25. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Carcinoma, Anaplastic*/drug therapy
Thyroid Carcinoma, Anaplastic*/pathology
Thyroid Neoplasms*/drug therapy
Thyroid Neoplasms*/pathology
Phenylurea Compounds*
Quinolines*
Antibodies, Monoclonal, Humanized*
Humans ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction.
Autorzy:
Muluhie M; Department of Pharmaceutical Sciences, University of Milan, Via G. Balzaretti 9, 20133, Milan, Italy.
Castiglioni L; Department of Pharmaceutical Sciences, University of Milan, Via G. Balzaretti 9, 20133, Milan, Italy.
Rzemieniec J; Department of Pharmaceutical Sciences, University of Milan, Via G. Balzaretti 9, 20133, Milan, Italy.
Mercuriali B; Department of Pharmaceutical Sciences, University of Milan, Via G. Balzaretti 9, 20133, Milan, Italy.
Gelosa P; Department of Pharmaceutical Sciences, University of Milan, Via G. Balzaretti 9, 20133, Milan, Italy.
Sironi L; Department of Pharmaceutical Sciences, University of Milan, Via G. Balzaretti 9, 20133, Milan, Italy. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3371. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Ventricular Remodeling*
Myocardial Infarction*/metabolism
Acetates*
Cyclopropanes*
Quinolines*
Sulfides*
Mice ; Animals ; Female ; Mice, Inbred C57BL ; Myocardium/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma.
Autorzy:
Xie L; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Sun X; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Xu J; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Liang X; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Liu K; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Sun K; Pathology Department, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Yang R; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Tang X; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China. .
Guo W; Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, P. R. China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 03; Vol. 24 (1), pp. 172. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Sarcoma*/pathology
Biphenyl Compounds*
Benzamides*
Morpholines*
Quinolines*
Indoles*
Pyridones*
Humans ; Irinotecan/therapeutic use ; Vincristine/therapeutic use ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of montelukast in preventing dengue with warning signs among patients with dengue: A multicenter, randomized, double-blind, placebo-controlled trial.
Autorzy:
Nitinai N; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Nasomsong W; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Chuerboonchai W; Department of Internal Medicine, Ananda Mahidol Hospital, Lopburi, Thailand.
Tweekittikul A; Department of Internal Medicine, Ananda Mahidol Hospital, Lopburi, Thailand.
Khingmontri V; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.; Department of Internal Medicine, Ananda Mahidol Hospital, Lopburi, Thailand.
Panuvatvanich B; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.; Department of Internal Medicine, Ananda Mahidol Hospital, Lopburi, Thailand.
Bangchuad T; Department of Internal Medicine, Fort Suranari Hospital, Nakhon Ratchasima, Thailand.
Pongpraijaroen M; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.; Department of Internal Medicine, Fort Suranari Hospital, Nakhon Ratchasima, Thailand.
Roongfa-Ngarm T; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.; Department of Internal Medicine, Fort Suranari Hospital, Nakhon Ratchasima, Thailand.
Vasikasin V; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.; Department of Internal Medicine, Ananda Mahidol Hospital, Lopburi, Thailand.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Feb 02; Vol. 18 (2), pp. e0011927. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Acetates*/therapeutic use
Severe Dengue*
Cyclopropanes*
Quinolines*
Sulfides*
Adult ; Humans ; Treatment Outcome ; Double-Blind Method ; Transaminases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High-throughput screening of the Saccharomyces cerevisiae genome for 2-amino-3-methylimidazo [4,5-f] quinoline resistance identifies colon cancer-associated genes.
Autorzy:
Dolan M; College of Nanotechnology, Science, and Engineering, State University of NewYork at Albany, Albany, NY 12203, USA.
St John N; College of Nanotechnology, Science, and Engineering, State University of NewYork at Albany, Albany, NY 12203, USA.
Zaidi F; College of Nanotechnology, Science, and Engineering, State University of NewYork at Albany, Albany, NY 12203, USA.
Doyle F; College of Nanotechnology, Science, and Engineering, State University of NewYork at Albany, Albany, NY 12203, USA.
Fasullo M; College of Nanotechnology, Science, and Engineering, State University of NewYork at Albany, Albany, NY 12203, USA.
Pokaż więcej
Źródło:
G3 (Bethesda, Md.) [G3 (Bethesda)] 2023 Dec 06; Vol. 13 (12).
Typ publikacji:
Journal Article
MeSH Terms:
Quinolines*/pharmacology
Quinolines*/metabolism
Colonic Neoplasms*
Arylamine N-Acetyltransferase*/genetics
Humans ; Cytochrome P-450 CYP1A2/metabolism ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism ; High-Throughput Screening Assays ; Early Detection of Cancer ; Mutagens ; Ribosomal Proteins ; DNA-Binding Proteins ; Ubiquitin-Protein Ligases ; DNA-Directed DNA Polymerase
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Novel 1,2,4-Triazole- and Tetrazole-Containing 4 H -Thiopyrano[2,3- b ]quinolines: Synthesis Based on the Thio-Michael/aza-Morita-Baylis-Hillman Tandem Reaction and Investigation of Antiviral Activity.
Autorzy:
Khramchikhin AV; Department of Chemistry and Technology of Organic Nitrogen Compounds, Saint Petersburg State Institute of Technology (Technical University), 26 Moskovsky Avenue, 190013 St. Petersburg, Russia.
Skryl'nikova MA; Department of Chemistry and Technology of Organic Nitrogen Compounds, Saint Petersburg State Institute of Technology (Technical University), 26 Moskovsky Avenue, 190013 St. Petersburg, Russia.; Saint Petersburg Federal Research Center of the Russian Academy of Sciences (SPC RAS), 39, 14th Line, 199178 St. Petersburg, Russia.
Gureev MA; Center of Bio- and Chemoinformatics, I. M. Sechenov First Moscow State Medical University, 8, Trubetskaya Street, Bld. 2, 119991 Moscow, Russia.; St. Petersburg School of Physics, Mathematics and Computer Science, HSE University, 16, Soyuza Pechatnikov Str., 190008 St. Petersburg , Russia.
Zarubaev VV; Saint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 St. Petersburg, Russia.
Esaulkova IL; Saint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 St. Petersburg, Russia.
Ilyina PA; Saint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 St. Petersburg, Russia.
Mammeri OA; Chemical Analysis and Materials Research Center, St. Petersburg State University, 26, Universitetskii Prospect, Petergof, 198504 St. Petersburg, Russia.
Spiridonova DV; Research Park, St. Petersburg State University, 26, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia.
Porozov YB; Center of Bio- and Chemoinformatics, I. M. Sechenov First Moscow State Medical University, 8, Trubetskaya Street, Bld. 2, 119991 Moscow, Russia.; St. Petersburg School of Physics, Mathematics and Computer Science, HSE University, 16, Soyuza Pechatnikov Str., 190008 St. Petersburg , Russia.
Ostrovskii VA; Department of Chemistry and Technology of Organic Nitrogen Compounds, Saint Petersburg State Institute of Technology (Technical University), 26 Moskovsky Avenue, 190013 St. Petersburg, Russia.; Saint Petersburg Federal Research Center of the Russian Academy of Sciences (SPC RAS), 39, 14th Line, 199178 St. Petersburg, Russia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Nov 04; Vol. 28 (21). Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Quinolines*/pharmacology
Molecular Docking Simulation ; Antiviral Agents/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel Epigenetic Modifiers of Histones Presenting Potent Inhibitory Effects on Adenoid Cystic Carcinoma Stemness and Invasive Properties.
Autorzy:
Pina PSS; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Stomatology, School of Dentistry, University of São Paulo, Sao Paulo 05508-270, Brazil.
Jang Y; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.
Emerick C; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.; Oral Diagnosis Department, Piracicaba School of Dentistry, State University of Campinas, Piracicaba 13414-903, Brazil.
Scarini JF; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.; Oral Diagnosis Department, Piracicaba School of Dentistry, State University of Campinas, Piracicaba 13414-903, Brazil.
Sousa SCOM; Department of Stomatology, School of Dentistry, University of São Paulo, Sao Paulo 05508-270, Brazil.
Squarize CH; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
Castilho RM; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 29; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Adenoid Cystic*/drug therapy
Carcinoma, Adenoid Cystic*/genetics
Carcinoma, Adenoid Cystic*/metabolism
Salivary Gland Neoplasms*/pathology
Hydroxylamines*
Quinolines*
Humans ; Histones/metabolism ; Cell Line, Tumor ; Epigenesis, Genetic ; Neoplasm Invasiveness
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 7407

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies